Skip to content

This Site is Intended for Healthcare Professionals Only

Search AI Powered

Latest Stories

RPS calls for increased Covid-19 protection for pharmacy teams

The Royal Pharmaceutical Society has joined over 20 other professional bodies and health organisations in demanding that the government and NHS increase Covid-19 protections for healthcare workers including community pharmacy teams.

In a meeting with government, NHS and public health officials on Thursday (June 3), the alliance of these organisations called for the UK infection prevention control guidance to be updated as well as making necessary arrangement for the supply of enhanced PPE for frontline healthcare workers.


“Whilst welcoming the government’s offer of further discussions, the alliance was disappointed that the UK guidance would not be updated at this time, despite emerging evidence and changes to guidance in the US and Europe,” the RPS said, sharing its concern over the safety of community pharmacy teams.

RPS president Sandra Gidley commented: “Supporting pharmacy teams and calling for appropriate PPE has been a key focus for the RPS during the pandemic.

“With frontline health and care staff under continued strain, we owe it to everybody to make sure they get the protection they deserve.

“As our understanding of Covid-19 evolves it’s vital that national guidance and support keep pace.”

The alliance believes that changes to the guidance are essential and should not be delayed. New Covid-19 variants and recent rises in positive cases make the case urgent for healthcare workers to be fully protected and provided with FFP3 masks when seeing patients, the RPS stressed.

More For You

NHS app to boost clinical trials

The focus is on encouraging people from underrepresented groups, including minorities from African and Asian heritage, to sign up for clinical trials.

iStock

Government to use NHS app to boost clinical trials

The government’s 10-Year Health Plan is expected to provide a fillip to clinical trials, and it plans to make use of the NHS App to encourage people to sign up as participants.

People will be able to sign up for the NIHR Be Part of Research service (bepartofresearch.uk) on the NHS App for the trials best suited to their interests and needs.

Keep ReadingShow less
US pharma bets big on China to snap up potential blockbuster drugs

Through June, US drugmakers have signed 14 deals potentially worth $18.3 billion to license drugs from China-based companies

US pharma bets big on China to snap up potential blockbuster drugs

US drugmakers are licensing molecules from China for potential new medicines at an accelerating pace, according to new data, betting they can turn upfront payments of as little as $80 million into multibillion-dollar treatments.

Through June, US drugmakers have signed 14 deals potentially worth $18.3 billion to license drugs from China-based companies. That compares with just two such deals in the year-earlier period, according to data from GlobalData provided exclusively to Reuters.

Keep ReadingShow less
Alliance Healthcare team raises thousands with charity bike ride to Paris

The Alliance Healthcare team

Alliance Healthcare team raises thousands with charity bike ride to Paris

Eight Alliance Healthcare team members raised over £55,000 for Theodora Children’s Charity by cycling from Surrey to Paris.

From June 13th-15th, the team took on the gruelling 300 mile cross-border Tour D’Alliance 2025 challenge and raised vital funds to support children who may be living with serious health challenges through Theodora Children’s Charity’s Giggle Doctor programme.

Keep ReadingShow less
Over four million flu vaccines across England in the 2024/25 winter flu season.

Over four million flu vaccines across England in the 2024/25 winter flu season.

CCA release

Community pharmacy administered over four million flu vaccines

Community pharmacy administered over four million flu vaccines across England in the 2024/25 winter flu season, the highest outside of the pandemic, according to the Company Chemists’ Association.

This is nearly 10 per cent higher than the number of flu vaccines administered in 2023/24.

Keep ReadingShow less
Chemotherapy-free leukaemia treatment

The trial found that a combination of two cancer drugs, ibrutinib and venetoclax, could perform better than chemotherapy among patients with chronic lymphocytic leukaemia.

iStock

Chemotherapy-free leukaemia treatment shows promise during trial

In a breakthrough in leukaemia research, scientists in the UK have tested a chemotherapy-free approach, involving a combination of targeted drugs, which may offer better outcomes.

The new treatment could radically change the way chronic lymphocytic leukaemia (CLL), the most common form of leukaemia in adults, is treated.

Keep ReadingShow less